Search Results 411-420 of 21311 for anti-TNF drugs

  1. Corticosteroid (Nasal Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Beconase; Beconase AQ; Flonase; Nasacort; Nasalide; Nasarel ...

  2. Meclizine, Buclizine, And Cyclizine (Oral Route, Parenteral Route) Proper Use - Mayo Clinic

    Dosing. The dose medicines in this class will be different for different patients. Follow your doctor's orders or the directions on the label. The following ...

  3. Tocilizumab-Aazg (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Tocilizumab-aazg injection is used alone or together with other medicines to treat moderate to severe active rheumatoid arthritis in patients who have been ...

  4. Anti-Inhibitor Coagulant Complex (Intravenous Route) Proper Use - Mayo Clinic

    Proper Use. Drug information provided by: Merative, Micromedex®. A doctor or other trained health professional will give you this medicine.

  5. Diclofenac (Ophthalmic Route) Description and Brand Names - Mayo Clinic

    This medicine is a topical nonsteroidal anti-inflammatory drug (NSAID). This medicine is available only with your doctor's prescription. This product is ...

  6. Neck pain - Diagnosis and treatment - Mayo Clinic

    Medications. Pain relievers might include nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen (Advil, Motrin IB, others) or naproxen sodium ...

  7. Naproxen (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  8. Overview - Mayo Clinic Comprehensive Cancer Center Research

    ... anti-cancer drugs forward through preclinical and clinical studies. Our program brings together cancer researchers from a variety of disciplines throughout ...

  9. Emerging treatments for multiple sclerosis - Mayo Clinic

    The majority of DMTs approved by the U.S. Food and Drug Administration (FDA) are effective at helping to manage relapsing-remitting MS. This form of MS affects ...

  10. Publications - Afsaneh Alavi, M.D. - Mayo Clinic

    2023 May 24; 188(6):808-810. View PubMed; Alavi A, Loftus EV Jr. Adalimumab Therapeutic Drug Monitoring Improves Treatment Outcome in Patients with Psoriasis.